🧠 Physician/Neuroscientist with 20+ years of experience in Healthcare & Life Sciences with Clinical Research, Digital Health, and Data Science expertise.

🏥 Passionate about improving healthcare and health outcomes via science, technology, innovation, and education with a focus on brain, mental, and behavioral health; CNS / neuropsychiatric / neurodegenerative disorders (Alzheimer's disease, dementia, depression, schizophrenia)

🧬 Precision Medicine, Biomarkers, Translational Medicine, Drug Development, Biotechnology

📊 Digital Health, AI/ML, Data Science, Analytics, Real-World Data / Real-World Evidence (RWD/RWE)

🍏 Health & Wellness, Preventive / Public Health, Lifestyle Medicine, Longevity Medicine, Social Determinants of Health

💡 ADVISORY & CONSULTING for digital health, medical device, and biotech / pharma companies

💬 LINKEDIN COACHING for Clinicians, Scientists, and Innovators

---------------
DISCLAIMERS: The views expressed are my own and don't necessarily reflect those of my employers or other 3rd parties. Any health-related content shared is for informational and/or educational purposes only and should not be considered medical advice.

Fair Use Disclaimer Under Section 107 of the U.S. Copyright Act of 1976: Copyrighted content is sometimes shared on my profile under the "Fair Use" allowance for purposes such as criticism, comment, news reporting, education, teaching, scholarship, and research. All rights and credits belong to the owners and/or authors of copyrighted content. No copyright infringement intended.

#healthcare #health #wellness #medicine #science #publichealth #neuroscience #mentalhealth #biotech #medtech #healthtech #digitalhealth #biomarkers #clinicalresearch #biotechnology #pharmaceuticals

Igor Korolev

Enjoyable Entrepreneur (4x) | Venture Partner | CEO | Chairman | WBAF Senator (G20) | Inventor | Speaker | Founder of Quantum Business Thinking™ | I help selected startups to streamline fundraising and boost valuation.

Is there a repeatable system for becoming investable?

After 15 years as Founder, CEO, and VC investor, I engineered Fundables OS™ to turn fundraising chaos into a scalable system. We enforced the four pillars of a winning round: Investor Fit, Narrative, Signals, and Conversion.

Background (proof):
▪️4x founder
▪️Venture Partner at Network.VC (100+ portfolio investments)
▪️Raised over $20 million in multiple rounds across several companies
▪️Invented the world's first FDA-cleared wrist wearable monitor
▪️Multiple industry awards

What I believe:
▪️Fundraising is not "pitch better." Its goal is to reduce decision risk.
▪️The raise-and-chase loop kills momentum.
▪️ Readiness beats persuasion.

I write about (what you'll see in my posts):
▪️Investor decision psychology (conviction, bias, risk reduction).
▪️Narrative that survives the IC (internal champion enablement).
▪️Signals that de-risk the round (traction, proof, authority, social proof).
▪️Conversion mechanics (cadence, momentum, "yes" engineering).
▪️Deal architecture (round structure, terms, data room readiness).

Example frameworks I publish: "The 7 Investor Conviction Levers", "The Internal Champion Package", "The Signals Stack."

Fundables OS™ (4 phases):
▪️Calibrate investor fit and Readiness
▪️Engineer narrative, data, and deal structure
▪️Signal traction that attracts the right investors
▪️Convert interest into committed capital

If you're building toward your next raise, start with a simple benchmark: the Fundability scorecard/diagnostic: https://dr-leon-slidakq8.scoreapp.com/

www.leoneisen.com

Leon Eisen, PhD - Founder, VC, Fundraising Coach

VCs ignore pitch decks...

Until they understand “why you.”

Last year, I met a founder with a flawless deck.

Six months later, they were stuck.

Now I look for one thing first: the “why them.”

After watching hundreds of startups stall after Seed, here’s what I learned:

A beautiful story can’t replace real momentum.

Seed and Series A aren’t raised with hype.
It’s earned with clarity and follow-through.

If you’re in the messy middle, what “why them” looks like in practice:

1. Customer pain is the obsession
 
Not features. 
Not buzzwords. 
Real, repeated pain.

2. The numbers match the stage
 
Forecasts are grounded. 
Assumptions are explicit.

3. A simple growth loop exists
 
One repeatable path from interest to revenue.

4. Focus is visible
 
They know who they’re not for, and say no fast.

5. Early wins look like a process
 
You can explain what worked, why, and how you’ll repeat it.

6. Operating cadence is real
 
Weekly priorities, accountability, and decisions that stick.

7. Learning is honest

Clear post-mortems, not excuses.

This is what I used to filter signal from noise in early-stage teams.
It turns chaos into a clean, fundable narrative.

What’s the hardest part for you right now: traction, team, or metrics? Comment on one word.

♻️ Repost to help founders in your network.
 Follow Leon Eisen, PhD for more VC insights.

Leon Eisen, PhD

4x Founder, VC Investor & Venture Partner | Creator of Fundables OS™ | Helped 100+ Seed-Series A teams become fundraise-ready and close rounds fast | Tracking toward $100M+ raised by founders I support

If you’re still pitching “potential,” 
Investors will treat you like a feature.
The new fundraising edge is simple: 

Publish proof.

This week wasn’t “a market.” 
It was a verdict.

I am sharing my updated funding tracker.

One round a week.

If you’re raising right now, the bar didn’t move evenly.
It polarized.

The signal was loud:
The market pays extreme prices for compounding advantage.
And discounts everything that looks replaceable.

You can see it in the tape:

Anthropic closed a $30B round at a $380B valuation.
Waymo announced $16B at a $126B valuation.

And the “normal” winners still looked like $100M to $500M rounds with published proof.

Here’s what to do in a polarized market:

1. Publishable metrics
 - Pick 5 numbers you’d let a reporter print today.

2. Compounding advantage proof
 - What gets stronger every month without matching cost?

3. Add outcomes on slide 3
 -If you sell into healthcare or other highly regulated markets, lead with measurable results and savings.

4. Architecture beats labels
 - In capital-heavy sectors, stage names matter less than milestone-gated tranches.

5. Engineer a syndicate
 - Build a strategic coalition, not a cap table.

If you are struggling with this when the clock is ticking?
It's weak proof, fuzzy milestones, or the wrong investor fit.

This is what I used when raises felt “fine,” but replies went cold.
It turns frustrating hope into measurable momentum.

What are you struggling with most right now when the clock is ticking: weak proof, fuzzy milestones, or the wrong investor fit?

♻️ Repost to help founders in your network.
 Follow Leon Eisen, PhD for more on raise and scale.

This week (Feb 9-15) wasn’t “a market.” It was a verdict. Capital didn’t spread. It concentrated. Hard. If you’re raising right now, the bar didn’t mo

Open article: What Rules VCs Quietly Changed This Week (And Founders Still Haven’t Noticed) by Leon Eisen, PhD • 13 min read

What Rules VCs Quietly Changed This Week (And Founders Still Haven’t Noticed)

taplio

The Battle

Igor Korolev

Leon Eisen, PhD - Founder, VC, Fundraising Coach

Followers

Posts

Engagements

Likes

Performance ScoreLeon Eisen, PhD - Founder, VC, Fundraising Coach's LinkedIn Performance

Ready to grow your LinkedIn presence?

taplio

The Battle

Igor Korolev

Leon Eisen, PhD - Founder, VC, Fundraising Coach

Followers

Posts

Engagements

Likes

Performance Score.css-goub6s{font-size:var(--chakra-fontSizes-md);font-weight:500;color:var(--chakra-colors-gray-600);display:block;margin-top:var(--chakra-space-1);}Leon Eisen, PhD - Founder, VC, Fundraising Coach's LinkedIn Performance

Ready to grow your LinkedIn presence?

Performance ScoreLeon Eisen, PhD - Founder, VC, Fundraising Coach's LinkedIn Performance